NKF with Bioengineering on sale to Morimatsu
Niederer Kraft Frey (NKF) advised the former owners on the sale of Swiss bioreactors specialist Bioengineering to the Japanese Morimatsu Group.
The parties
Morimatsu is a provider of core equipment, process systems and digital intelligence integrated plant solutions. The Japanese company is active at global level and listed at the stock exchange of Hongkong.
Owning subsidiaries in China, Korea and the USA, Bioengineering specialises in the development and production of bioreactors, especially fermenters for the pharmaceutical, biotech and novel food industries.
The NKF team
Corporate/M&A partners Andreas Casutt (pictured left) and Manuel Werder (pictured right) led the NKF team on the matter, working with associates Naomi Loretz and Nadine Wanner (both corporate/M&A).
